MISHAN ORLY 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Jan 28, 2021
Insider Transaction Report
Form 4
MISHAN ORLY
Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-01-26−38,450→ 426,913 totalExercise: $3.50Exp: 2029-06-25→ Common Stock (38,450 underlying) - Exercise/Conversion
Common Stock
2021-01-26$3.50/sh+38,450$134,575→ 38,450 total
Footnotes (1)
- [F1]25% of the shares subject to this option vested and became exercisable on July 15, 2020, with remainder vesting in 36 equal monthly installments thereafter.